Roivant Sciences (ROIV) Soars 19.4% as Pipeline Drugs Progress

We recently published 10 Easy Double-Digit Gainers. Roivant Sciences Ltd. (NASDAQ:ROIV) was one of the best performers last week. Roivant saw its share prices jump by 19.4 percent week-on-week, hitting a new all-time high, as investors snapped up shares following encouraging results from its pipeline projects, with one already seeking a new drug application (NDA) approval. In Friday’s trading, the stock jumped to its highest price of $25.95 before trimming a few cents to finish the day just up by 22.14 p ...